Results 131 to 140 of about 156,401 (247)

Novel glutamatergic drugs for the treatment of mood disorders

open access: yesNeuropsychiatric Disease and Treatment, 2013
Kyle AB Lapidus, Laili Soleimani, James W MurroughMood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USAAbstract: Mood disorders are common and debilitating, resulting in a significant ...
Murrough JW, Lapidus KAB, Soleimani L
doaj  

A comparative exploration of monoamine neurotransmitter transport disorders: mechanisms, clinical manifestations, and therapeutic approaches. [PDF]

open access: yesJ Med Life
Al Sari RR   +9 more
europepmc   +1 more source

Utilization of Medicinal Plants in Mental Disorders: Neuroplasticity and Neuroprotection in Biomodels. [PDF]

open access: yesBrain Sci
Estela-Zape JL   +3 more
europepmc   +1 more source

The neurochemical basis of photic entrainment of the circadian pacemaker [PDF]

open access: yes
Circadian rhythmicity in mammals is controlled by the action of a light-entrainable hypothalamus, in association with two cell clusters known as the supra chiasmatic nuclei (SCN).
Buckley, Becky   +2 more
core   +1 more source

Neuroinflammation-A Crucial Factor in the Pathophysiology of Depression-A Comprehensive Review. [PDF]

open access: yesBiomolecules
Sălcudean A   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy